09/19/2026
Saffron for ADHD in children ages 6 years and older (there are no safety studies in younger children).
AI query:
Most of the clinical data on saffron's psychiatric applications stems from ADHD research.
The Research: Small, short-term studies (typically 6 to 8 weeks) have compared standardized saffron extract against methylphenidate (Ritalin/Concerta). A landmark 2019 study and subsequent 2022 clinical trials found that saffron was comparable to stimulants in overall symptom reduction for children and adolescents.
Hyperactivity vs. Inattention: Studies indicate that saffron is highly effective for reducing symptoms of hyperactivity and impulsivity, sometimes even outperforming stimulants in this area. However, standard stimulant medications remain significantly more effective at treating inattention.
How It Works: Saffron contains active compounds like crocin and safranal. Scientists believe it works similarly to ADHD medications by stimulating and balancing neurotransmitters like dopamine, serotonin, and norepinephrine.
The Sleep Benefit: Unlike central nervous system stimulants—which frequently cause insomnia and appetite loss—saffron has been shown to improve sleep quality and significantly reduce the time it takes for individuals with ADHD to fall asleep.
_______________________________________________________________________
Saffron for Autism Spectrum Disorder (ASD)- again, there are no safety studies in children less than 6 years old.
While there are fewer direct clinical trials for autism compared to ADHD, researchers are increasingly looking at saffron due to the significant neurological overlap between the two conditions.
Neuroprotection and Inflammation: Children with autism frequently exhibit higher markers of oxidative stress and neuroinflammation. Saffron acts as a powerful antioxidant and anti-inflammatory agent. By combating this cellular damage, it is thought to support overall brain health and neurodevelopmental balance.
Behavioral and Emotional Support: Early data suggests that saffron's ability to modulate glutamate and GABA pathways may help alleviate core ASD-associated symptoms, such as reducing irritability, supporting behavioral flexibility, and calming anxiety.
___________________________________________________________________
Important Considerations and Safety
If you are considering using saffron as a supplement, keep the following caveats in mind:
Lack of Regulation: Because saffron is sold as a dietary supplement, it is not strictly regulated by the FDA. Quality, purity, and active compound concentrations vary wildly between brands. Look for standardized extracts (often labeled as affron® or Saffr’Activ) that specify the amount of active crocin.
Dosing: In pediatric clinical trials, typical doses ranged between 20 mg to 30 mg per day (often split into two doses), while adult trials used around 30 mg. This is much higher than the culinary amounts used in cooking. No universal, weight-based pediatric dosing standard exists yet.
Side Effects & Interactions: Saffron is generally well-tolerated at therapeutic doses, though minor side effects like mild nausea, dizziness, or headaches can occur. Crucially, saffron can interact with other medications, particularly antidepressants (SSRIs), and high doses must be avoided during pregnancy.
REFERENCES:
Blasco-Fontecilla H, Moyano-Ramírez E, Méndez-González O,
Rodrigo-Yanguas M, Martin-Moratinos M, Bella-Fernández M. Effectivity of Saffron Extract (Saffr'Activ) on Treatment for Children and Adolescents with Attention Deficit/Hyperactivity Disorder (ADHD): A Clinical Effectivity Study.
Nutrients. 2022 Sep 28;14(19):4046. doi: 10.3390/nu14194046. PMID: 36235697; PMCID: PMC9573091.
Seyedi-Sahebari, S., Farhang, S., Araj-Khodaei, M., Akhondzadeh, S., Naseri, A., Sanaie, S., & Frounchi, N. (2024).
The Effects of Crocus sativus (Saffron) on ADHD: A Systematic Review.
Journal of Attention Disorders, 28(1), 14–24. https://doi.org/10.1177/10870547231203176
Sahar Golpour- Hamedani, Makan Pourmasoumi, Sudiyeh Hejri Zarifi, Gholamreza Askari,Tannaz Jamialahmadi, Mohammad Bagherniya, Amirhossein Sahebkar.
Therapeutic effects of saffron and its components on neurodegenerative diseases,
Heliyon, Volume 10, Issue 2, 2024, e24334,
ISSN 2405-8440,
https://doi.org/10.1016/j.heliyon.2024.e24334.
(https://www.sciencedirect.com/science/article/pii/S2405844024003657)
Kehtari T, Tovar DC, Epstein D, Junquera P.
From Mood to Memory: Unlocking Saffron's Potential in Brain Health.
Cureus. 2025 Apr 24;17(4):e82924. doi:
10.7759/cureus.82924. PMID: 40416274; PMCID: PMC12103703.